MyMD Pharmaceuticals Inc (MYMD)

[leifsmith]

Although the molecules are, at one level, similar, at another more detailed level they are very different. Anatabloc has two six carbon rings, and MYMD-1 has one six carbon ring and one five carbon ring.

This is actually a major difference.

The biochemistry of living systems can be so sensitive that even a difference of a single sugar molecule in two human blood types can make infusion of the "wrong" blood fatal to the recipient. The "small" difference has big consequences.

Patrick Cox, an early researcher and writer on Anatabloc, has told me that the MYMD-1 molecule is significantly better than the Anatabloc molecule. It will be interesting to watch that difference become more clear.

I don't yet understand how what might be expected from the anatabine citrate molecule (Anatabloc) and the MYMD-1 molecule are not the same. The described effects seem to be the same. Maybe it's a difference in effectiveness? or are some health states addressed by MYMD-1 that Anatabloc could not touch?